Visualitza per autor "Azaro Pedrazzoli, Analía Beatriz"
Ara mostrant els elements 1-8 d 8
-
A Phase 1/2A trial of idroxioleic acid: first-in-class sphingolipid regulator and glioma cell autophagy inducer with antitumor activity in refractory glioma
Lopez, Juanita; Lai-Kwon, Julia; Molife, L. R.; Welsh, Liam; Tunariu, Nina; Roda, Desamparados; Azaro Pedrazzoli, Analía Beatriz; Rodon, Jordi (Springer Nature, 2023-09-21) -
A Phase Ib/II, open-label, multicenter study of INC280 (capmatinib) alone and in combination with buparlisib (BKM120) in adult patients with recurrent glioblastoma
Azaro Pedrazzoli, Analía Beatriz; De Vos, Filip; Sepúlveda, Juan Manuel; Yung, W. K. Alfred; Wen, Patrick Y.; van den Bent, Martin (Springer, 2020-01) -
High p16 expression and heterozygous RB1 loss are biomarkers for CDK4/6 inhibitor resistance in ER+ breast cancer
Palafox Sánchez, Marta; Monserrat Vicente, Laia; Gonzalez-Perez, Abel; Antunes de Melo Oliveira, Ana Mafalda; Òdena, Andreu; Sanchez-Guixe, Monica; Capelan Rodríguez, Marta; Azaro Pedrazzoli, Analía Beatriz; Rodriguez Ferreiro, Olga; Guzman Torres, Marta; Grueso Gragera, Judit; Viaplana Donato, Cristina; Hernandez Losa, Javier; Arribas López, Joaquin Vicente; Nuciforo, Paolo Giovanni; Serra Elizalde, Violeta; Villacampa Javierre, Guillermo; Bellet Ezquerra, Meritxell; Saura Manich, Cristina; Dienstmann, Rodrigo (Nature Portfolio, 2022-09-07) -
Molecular correlates of response to capmatinib in advanced non-small-cell lung cancer: clinical and biomarker results from a phase I trial
Schuler, Martin; Berardi, R.; Lim, Darren Wan-Teck; de Jonge, M.; Azaro Pedrazzoli, Analía Beatriz; Bauer, Todd (Elsevier, 2020-06) -
Palbociclib and ribociclib in breast cancer: consensus workshop on the management of concomitant medication
Ahmad Diaz, Faten; Villanueva, Rafael; Valdivia Vadell, Carolina; Palomino-Doza, Julián; Ruiz, Ada; Azaro Pedrazzoli, Analía Beatriz; Aguilar Company, Juan; Martín Pérez, Anastasio; Escriva de Romaní Muñoz, Santiago Ignacio; Alcalde Rodrigo, Maria; Ruiz Camps, Isabel; Bellet Ezquerra, Meritxell; Reyes López, Victoria (SAGE Publications, 2019-05-10) -
Phase 1 study of capmatinib in MET-positive solid tumor patients: Dose escalation and expansion of selected cohorts
Su, Wu-Chou; Schuler, Martin; Nam, Do-Hyun; Lim, Darren Wan-Teck; Azaro Pedrazzoli, Analía Beatriz; Bauer, Todd; Bang, Yung-Jue (Wiley, 2020-02) -
Phase I prognostic online (PIPO): A web tool to improve patient selection for oncology early phase clinical trials
Matos Garcia, Ignacio; Hierro Carbó, Cinta; Martín Liberal, Juan Jesús; Berche, Roger; Pedrola Gómez, Anna; Braña Garcia, Irene; Azaro Pedrazzoli, Analía Beatriz; Vieito Villar, Maria; Saavedra Gadea, Omar; Gardeazabal, Itziar; Hernando Calvo, Alberto; Alonso-Casal, Guzman; Galvao De Aquiar, Vladimir; Ochoa de Olza Amat, Maria; Ros Montañá, Fco. Javier; Viaplana Donato, Cristina; Elez Fernandez, Mª Elena; Rodon Ahnert, Jordi; Macarulla Mercadé, Teresa; Oaknin Benzaquen, Ana Mazaltob; Carles Galceran, Joan; Felip Font, Enriqueta; Tabernero Caturla, Josep; Garralda Cabanas, Elena; Villacampa Javierre, Guillermo; Saura Manich, Cristina; Muñoz Couselo, Eva; Dienstmann, Rodrigo (Elsevier, 2021-09) -
Phase I/IIa, open-label, multicentre study to evaluate the optimal dosing and safety of ODM-203 in patients with advanced or metastatic solid tumours
Bono, Petri; Massard, Christophe; Peltola, Katriina J; Azaro Pedrazzoli, Analía Beatriz; Italiano, Antoine; Kristeleit, Rebecca S; Rodon Ahnert, Jordi (BMJ, 2020-12)